|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304.33 USD | -0.84% |
|
+9.76% | -7.81% |
| 09/04 | Piper Sandler Adjusts Price Target on UnitedHealth to $399 From $390, Maintains Overweight Rating | MT |
| 08/04 | US stocks end mixed on signs of progress before Trump's Iran deadline | RE |
Evolution of the Average Target: UnitedHealth Group Inc.
Evolution of the Target Price: UnitedHealth Group Inc.
Changes in Analyst Recommendations: UnitedHealth Group Inc.
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +18.61% | |||||
| +24.9% | |||||
| +22.04% | |||||
| +10.37% | |||||
| +16.07% | |||||
| +3.55% | |||||
| +24.39% | |||||
| +68.43% | |||||
| +45.94% | |||||
| +63.6% | |||||
| Average | +29.79% | |||||
| Weighted average by Cap. | +19.59% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Piper Sandler | |
| HSBC | |
| Bernstein | |
| Raymond James | |
| Wolfe Research | |
| Mizuho Securities | |
| Truist Securities | |
| JPMorgan Chase | |
| Wells Fargo Securities | |
| TD Cowen | |
| Barclays | |
| Oppenheimer | |
| UBS | |
| BofA Securities | |
| RBC Capital Markets | |
| Morgan Stanley | |
| Evercore ISI | |
| Jefferies & Co. | |
| Goldman Sachs | |
| Deutsche Bank Securities | |
| Leerink Partners | |
| Baird | |
| KeyBanc Capital Markets | |
| Nephron Research | |
| Argus | |
| Stephens Inc. | |
| Cantor Fitzgerald | |
| SVB Securities LLC | |
| Morningstar | |
| Loop Capital | |
| Credit Suisse | |
| BMO Capital | |
| SVB Leerink | |
| RBC | Ben Hendrix |
| Edward Jones | |
| Morgan Joseph | |
| Citigroup | |
| Seaport Global Securities |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UNH Stock
- Consensus UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition